Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Review Status	Status Date	View
JXSB2300001	帕博利珠单抗注射液	pembrolizumab	Injection	Biological Products(2.2)	Supplementary Application	2023-01-04				view
JTS2400017	favezelimab帕博利珠单抗注射液	favezelimab;pembrolizumab	Injection	Biological Products	Disposable Import Drug Application	2024-03-12				view
JXSS2101033	帕博利珠单抗注射液	pembrolizumab	Injection	Biological Products(2.2)	Import Drug Application	2021-11-26				view
JXSB2101016	帕博利珠单抗注射液	pembrolizumab	Injection	Biological Products(2.2)	Supplementary Application	2021-06-02				view
JYSB2400009	帕博利珠单抗注射液	pembrolizumab	Injection	Biological Products	Supplementary Application	2024-01-18				view
JXSS2300028	帕博利珠单抗注射液	pembrolizumab	Injection	Biological Products(2.2)	Import Drug Application	2023-03-29				view
JXSL2100041	帕博利珠单抗注射液	pembrolizumab	Injection	Biological Products(2.2)	Import Drug Application	2021-03-11	Merck Sharp & Dohme Corp	In Review	2021-03-10	view
JXSB2101078	帕博利珠单抗注射液	pembrolizumab	Injection	Biological Products(2.2)	Supplementary Application	2021-10-26				view
JXSL2101151	帕博利珠单抗注射液	pembrolizumab	Injection	Biological Products(2.2)	Import Drug Application	2021-12-24				view
JXSL2000016	帕博利珠单抗注射液	pembrolizumab	Injection	Biological Products	Import Drug Application	2020-02-03	Merck Sharp & Dohme Corp	In Review	2020-01-23	view
JXSB2200015	帕博利珠单抗注射液	pembrolizumab	Injection	Biological Products(2.2)	Supplementary Application	2022-01-29				view
JXSB2300106	帕博利珠单抗注射液	pembrolizumab	Injection	Biological Products	Supplementary Application	2023-08-30				view
JXSB2101079	帕博利珠单抗注射液	pembrolizumab	Injection	Biological Products	Supplementary Application	2021-10-27				view
JXSB2101049	帕博利珠单抗注射液	pembrolizumab	Injection	Biological Products	Supplementary Application	2021-08-19				view
JXSB2200136	帕博利珠单抗注射液	pembrolizumab	Injection	Biological Products	Supplementary Application	2022-10-22				view
JXSB2101058	帕博利珠单抗注射液	pembrolizumab	Injection	Biological Products(2.2)	Supplementary Application	2021-09-13				view
JYSB2300201	帕博利珠单抗注射液	pembrolizumab	Injection	Biological Products(3.1)	Supplementary Application	2023-12-01				view
JXSS2300011	帕博利珠单抗注射液	pembrolizumab	Injection	Biological Products(3.1)	Import Drug Application	2023-01-18				view
JXSL2400074	帕博利珠单抗注射液	pembrolizumab	Injection	Biological Products(2.2)	Import Drug Application	2024-04-10				view
JXSS2200010	帕博利珠单抗注射液	pembrolizumab	Injection	Biological Products(3.1)	Import Drug Application	2022-03-08				view